Structure-activity relationships of novel potent MurF inhibitorsYU GUI GU; FLORJANCIC, Alan S; STAMPER, Geoffrey F et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 1, pp 267-270, issn 0960-894X, 4 p.Article

Impact of exercise on bone health and contraindication of oral contraceptive use in young womenWEAVER, Connie M; TEEGARDEN, Dorothy; PEACOCK, Munro et al.Medicine and science in sports and exercise. 2001, Vol 33, Num 6, pp 873-880, issn 0195-9131Article

Novel Protease Inhibitors (PIs) Containing Macrocyclic Components and 3(R),3a(S),6a(R)-bis-Tetrahydrofuranylurethane That Are Potent against Multi-PI-Resistant HIV-1 Variants In VitroTOJO, Yasushi; KOH, Yasuhiro; AMANO, Masayuki et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 8, pp 3460-3470, issn 0066-4804, 11 p.Article

Design of HIV-1 Protease Inhibitors with Pyrrolidinones and Oxazolidinones as Novel P1'-Ligands To Enhance Backbone-Binding Interactions with Protease: Synthesis, Biological Evaluation, and Protein—Ligand X-ray Studies^∞GHOSH, Arun K; LESHCHENKO-YASHCHUK, Sofiya; MITSUYA, Hiroaki et al.Journal of medicinal chemistry (Print). 2009, Vol 52, Num 13, pp 3902-3914, issn 0022-2623, 13 p.Article

Nonsteroidal selective glucocorticoid modulators: the effect of C-5 alkyl substitution on the transcriptional activation/repression profile of 2,5-dihydro-10-methoxy-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolinesELMORE, Steven W; COGHLAN, Michael J; JACOBSON, Peer B et al.Journal of medicinal chemistry (Print). 2001, Vol 44, Num 25, pp 4481-4491, issn 0022-2623Article